Circulating matrix metalloproteinase-9 level is associated with cerebral white matter hyperintensities in non-stroke individuals

Eur Neurol. 2014;72(3-4):234-40. doi: 10.1159/000362876. Epub 2014 Sep 20.

Abstract

Backgrounds: The pathogenesis of cerebral white matter hyperintensities (WMH) has been poorly understood. Our aim was to investigate the association of circulating proteins, the biomarkers of inflammation, blood-brain barrier (BBB) dysfunction, and thrombosis with WMH in non-stroke individuals.

Methods: Demographic, laboratory, and brain magnetic resonance imaging parameters were prospectively analyzed in 137 subjects. The relationship between plasma interleukin-6, tumor necrosis factor-α, matrx-metalloproteinase-9 (MMP-9), plasminogen activator inhibitor-1 and overt WMH (Fazekas grading score ≥2) was analyzed.

Results: In univariate analysis, old age, high blood pressure, history of hypertension, and elevated plasma MMP-9 level were associated with overt WMH. In multivariate analysis, plasma MMP-9 still maintained a significant association with WMH. Plasma MMP-9 level was weakly but significantly associated with WMH volume (r = 0.232, p = 0.006). All the other circulating proteins examined failed to demonstrate a significant relationship with WMH.

Conclusions: Plasma MMP-9 is associated with pathophysiology of WMH development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Blood-Brain Barrier / physiopathology
  • Cerebral Cortex / pathology*
  • Female
  • Humans
  • Interleukin-6 / blood
  • Leukoencephalopathies / blood*
  • Leukoencephalopathies / pathology*
  • Magnetic Resonance Imaging
  • Male
  • Matrix Metalloproteinase 9 / blood*
  • Middle Aged
  • Plasminogen Activator Inhibitor 1 / blood
  • Statistics, Nonparametric
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Interleukin-6
  • Plasminogen Activator Inhibitor 1
  • Tumor Necrosis Factor-alpha
  • Matrix Metalloproteinase 9